Twelve-Year Longitudinal Trends in Trachoma Prevalence among Children Aged 1-9 Years in Amhara, Ethiopia, 2007-2019.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
18 01 2021
Historique:
received: 16 10 2020
accepted: 23 11 2020
pubmed: 4 2 2021
medline: 16 2 2022
entrez: 3 2 2021
Statut: epublish

Résumé

Trachoma control in the Amhara region of Ethiopia, where all districts were once endemic, began in 2001 and attained full scale-up of the Surgery, Antibiotics, Facial cleanliness, and Environmental improvement (SAFE) strategy by 2010. Since scaling up, the program has distributed approximately 14 million doses of antibiotic per year, implemented village- and school-based health education, and promoted latrine construction. This report aims to provide an update on the prevalence of trachoma among children aged 1-9 years as of the most recent impact or surveillance survey in all 160 districts of Amhara. As of 2019, 45 (28%) districts had a trachomatous inflammation-follicular (TF) prevalence below the 5% elimination threshold. There was a statistically significant relationship between TF prevalence observed at the first impact survey (2010-2015) and eventual achievement of TF < 5% (2015-2019). Of the 26 districts with a first impact survey < 10% TF, 20 (76.9%) had < 5% TF at the most recent survey. Of the 75 districts with a first survey between 10% and 29.9% TF, 21 (28.0%) had < 5% TF at the most recent survey. Finally, among 59 districts ≥ 30% TF at the first survey, four (6.8%) had < 5% TF by 2019. As of 2019, 30 (18.8%) districts remained with TF ≥ 30%. Amhara has seen considerable reductions of trachoma since the start of the program. A strong commitment to the SAFE strategy coupled with data-driven enhancements to that strategy is necessary to facilitate timely elimination of trachoma as a public health problem regionally in Amhara and nationwide in Ethiopia.

Identifiants

pubmed: 33534757
doi: 10.4269/ajtmh.20-1365
pii: tpmd201365
pmc: PMC8045658
doi:
pii:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1278-1289

Auteurs

Eshetu Sata (E)

1Trachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.

Andrew W Nute (AW)

2Trachoma Control Program, The Carter Center, Atlanta, Georgia.

Tigist Astale (T)

1Trachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.

Demelash Gessese (D)

1Trachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.

Zebene Ayele (Z)

1Trachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.

Mulat Zerihun (M)

1Trachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.

Ambahun Chernet (A)

1Trachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.

Berhanu Melak (B)

1Trachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.

Kimberly A Jensen (KA)

2Trachoma Control Program, The Carter Center, Atlanta, Georgia.

Mahteme Haile (M)

3Amhara Public Health Institute, Research and Technology Transfer Directorate, Bahir Dar, Ethiopia.

Taye Zeru (T)

3Amhara Public Health Institute, Research and Technology Transfer Directorate, Bahir Dar, Ethiopia.

Melkamu Beyen (M)

4Amhara Regional Health Bureau, Health Promotion and Disease Prevention, Bahir Dar, Ethiopia.

Adisu Abebe Dawed (AA)

4Amhara Regional Health Bureau, Health Promotion and Disease Prevention, Bahir Dar, Ethiopia.

Fikre Seife (F)

5Federal Ministry of Health, Disease Prevention and Control Directorate, Addis Ababa, Ethiopia.

Zerihun Tadesse (Z)

1Trachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.

Elizabeth Kelly Callahan (EK)

2Trachoma Control Program, The Carter Center, Atlanta, Georgia.

Jeremiah Ngondi (J)

6RTI International, International Development (Global Health), London, United Kingdom.

Scott D Nash (SD)

2Trachoma Control Program, The Carter Center, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH